News from synapse biomedical inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 15, 2015, 10:22 ET
Synapse Biomedical's Network Neuroprosthesis

Synapse Biomedical and Case Western Reserve University Announce Collaboration to Commercialize Advanced Neurostimulation Technology

With the support of a $3 million Ohio Third Frontier Innovation Platform Program grant, Synapse Biomedical Inc. will lead the commercialization of...

Oct 13, 2015, 12:42 ET
NeuRx Diaphragm Pacing System FDA approved for ALS patients with chronic hypoventilation and spinal cord injury (SCI) patients.

U.S. Diaphragm Pacing Study in ALS Continues Enrollment: The Post Approval Study's (PAS) Interim Data Showed Device Safety and Median Survival Post-Implant of 20.9 months

 Synapse Biomedical Inc. (www.synapsebiomedical.com) reported today that the U.S. multi-center, Post Approval Study (PAS) studying the use of...

Sep 21, 2015, 18:20 ET
NeuRx Diaphragm Pacing System FDA, HDEapproved ALS & Spinal Cord Injury patients

U.S. ALS Diaphragm Pacing Study Showing Safety and Benefit Trend Is Suspended Due to Slow Recruitment

 Synapse Biomedical Inc. (www.synapsebiomedical.com) received word that the Northeast ALS Consortium (NEALS) Data and Safety Monitoring Board...

Aug 25, 2015, 18:10 ET
NeuRx Diaphragm Pacing System extends ALS survival post-implant

Multi-center ALS Study Using the NeuRx® Diaphragm Pacing System™ (DPS) Shows Safety and Survival Post-Implant of 20.9 Months

 Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today that an abstract regarding Synapse Biomedical's Post Approval Study (PAS),...

Aug 11, 2015, 13:43 ET
Synapse Biomedical.

A Decade of NeuRx DPS® Use: Analysis of Diaphragm Pacing in 214 Patients with Lou Gehrig's Disease (ALS) Shows Safety and Improved Survival Benefit

 Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today that an abstract regarding a decade of use of the NeuRx Diaphragm...

Aug 07, 2015, 15:56 ET
Synapse Biomedical.

Next generation modeling sees into the future for ALS patients: Origent Data Sciences accurately predicts function and survival of patients using Diaphragm Pacing System

 Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today that the abstract Analysis of Function and Survival in ALS Patients with...

Sep 30, 2014, 08:30 ET
Synapse Biomedical.  (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients

 Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has completed the enrollment of the post-approval study of its NeuRx...

Dec 18, 2013, 14:52 ET
Synapse Biomedical Inc.  (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives $2.4 Million

Supports Next Generation of NeuRx® Platform  Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has been awarded...

Nov 13, 2013, 13:00 ET
Synapse Biomedical.  (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives Canadian Health Ministry Approval of NeuRx Diaphragm Pacing System (DPS)® For Spinal Cord Injury Breathing Applications

 Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has received approval from the Health Canada for its NeuRx DPS®...

Sep 30, 2011, 16:04 ET

Synapse Biomedical obtient l'approbation de la FDA pour le système d'entrainement de diaphragme NeuRx (DPS)® pour traiter la sclérose latérale amyotrophique (SLA)

Synapse Biomedical, Inc. a annoncé que la U.S. Food and Drug Administration (FDA) avait approuvé le Système d'entrainement de...

Sep 30, 2011, 14:44 ET

Synapse Biomedical erhält FDA-Zulassung für das NeuRx Diaphragm Pacing System (DPS)® bei der Behandlung von Amyotropher Lateralsklerose (ALS)

Synapse Biomedical, Inc. gab heute bekannt, die US-Arzneimittelbehörde (FDA) habe das NeuRx Diaphragm Pacing System(DPS)®...

Sep 29, 2011, 14:54 ET

Synapse Biomedical recibe la aprobación de la FDA para el NeuRx Diaphragm Pacing System (DPS)®

- Synapse Biomedical recibe la aprobación de la FDA para el NeuRx Diaphragm Pacing System (DPS)® para tratar la esclerosis lateral...

Sep 29, 2011, 09:56 ET
Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) - synapsebiomedical.com. (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)® to Treat Amyotrophic Lateral Sclerosis (ALS)

Synapse Biomedical, Inc. announces that the U.S. Food and Drug Administration (FDA) has approved its NeuRx Diaphragm Pacing System (DPS)® for...

Oct 08, 2010, 11:47 ET
Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) - synapsebiomedical.com. (PRNewsFoto/Synapse Biomedical Inc.)

Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)

Synapse Biomedical Inc. announces today that they have received the U.S. Food and Drug Administration (FDA) designation of the NeuRx Diaphragm...

Jun 18, 2008, 01:00 ET
A F AMERICAN SOCIETY FOR ENGINEERING EDUCATION LOGO AMERICAN SOCIETY FOR ENGINEERING EDUCATION LOGO

American Society for Engineering Education logo. (PRNewsFoto/American Society for Engineering Education)[TK]
 WASHINGTON, DC UNITED STATES
 09/09/2009

Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications

CLEVELAND, June 18 /PRNewswire/ -- Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today it has received approval from the U.S....